IPP Bureau
Granules India recalls one batch of Naproxen Sodium 220mg tablets
By IPP Bureau - September 13, 2021
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
Advanced Enzyme supplements pass clinical trials for efficacy
By IPP Bureau - September 13, 2021
This clinical study demonstrated that the 14-day regimen of ImmunoSEB and ProbioSEB CSC3 resolved post-Covid-19 fatigue symptoms and improved patients' functional status and quality of life
Everest Medicines ties up with Providence Therapeutics to supply Covid-19 vaccines in Asia
By IPP Bureau - September 13, 2021
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
US FDA grants Soligenix Orphan Drug Designation for the treatment of T-cell lymphoma
By IPP Bureau - September 12, 2021
Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma
US FDA grants Jardiance Breakthrough Therapy designation for heart failure with a preserved ejection fraction
By IPP Bureau - September 12, 2021
The designation is based on results from the EMPEROR-Preserved phase III trial, which established Jardiance as the first therapy to show statistically significant improvement in heart failure outcomes in adults with heart failure with a preserved ejection fraction
Firstsource Solutions launch Healthcare Cloud
By IPP Bureau - September 12, 2021
The platform revolutionizes how providers deliver financial services by radically simplifying the patient financial experience
Whole Slide Imaging scanners in India soon
By IPP Bureau - September 12, 2021
Crosscope and KFBIO join forces to lead digital transformation for pathology in India and emerging markets
India develops Covid-19 vaccine tracker
By IPP Bureau - September 10, 2021
The tracker gives week by week coverage of the first and second dose of vaccine and also their effectiveness
DiaCarta receives CE/IVD for its Covid-19 screening test
By IPP Bureau - September 10, 2021
This test can be run on commonly available qPCR cyclers, thereby, bypassing the need to perform expensive and time-consuming Next-Generation Sequencing
Zoho to invest US $ 5 million in Voxelgrids, a startup that builds MRI scanners
By IPP Bureau - September 09, 2021
Over 70 per cent of the world’s population have no access to MRI scanners and the situation is not that encouraging in India where there are only 0.4 MRI scanners per thousand people
.jpg "Telangana commences drone delivery of vaccines from Sept 9")
Telangana commences drone delivery of vaccines from Sept 9
By IPP Bureau - September 09, 2021
The much-awaited drone delivery trials for the delivery of medicines and vaccines will be held in Vikarabad, Hyderabad from 9th September till 17th October.
Novavax initiates Phase 1/2 trials combining vaccine for Covid-19 and seasonal influenza
By IPP Bureau - September 09, 2021
First participants enrolled in Phase 1 clinical trial of combination NanoFlu/NVX-CoV2373 vaccine with Matrix-M adjuvant. The Phase 1/2 study will also evaluate immunogenicity and safety
Evexia Lifecare on expansion mode
By IPP Bureau - September 09, 2021
The company plans to enter the formulation business in January 2022. It has also opened a branch in Hyderabad to trade pharmaceutical chemicals
Eirion Therapeutics mandates HTL Biotechnology to be its exclusive Botulinum API manufacturer.
By IPP Bureau - September 09, 2021
HTL will build, validate and operate a botulinum manufacturing facility in the US
DCGI grants EUA to Truenat for conducting Nipah virus tests
By IPP Bureau - September 09, 2021
Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis
